Report Viewer

NINDS CDE Notice of Copyright
PROMIS Item Bank v1.2 - Global Health
Availability
Please visit this website for more information about the instrument: PROMIS Scale v1.2 - Global Health
Classification
Disorder-specific classifications were assigned with respect to the overall collection of PROMIS measures. Use of individual item banks or short forms depends upon the study design or type of research involved unless additional guidance is noted.
 
NeuroRehab Supplemental - Highly Recommended:
Recommendations for Use: Indicated for studies requiring a Global Health-Related Quality of Life measure.
 
Supplemental - Highly Recommended: Stroke, Congenital Muscular Dystrophy (CMD) in studies of psychosocial functioning, quality-of-life, outcome, and long-term adjustment studies.
 
Supplemental: Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Chiari I Malformation (CM), Epilepsy, Friedreich's Ataxia (FA), Headache, Huntington's Disease (HD), Mitochondrial Disease (Mito), Multiple Sclerosis (MS), Myasthenia Gravis (MG), Neuromuscular Diseases (NMD), Duchenne/Becker Muscular Dystrophy (DMD/BMD), Spinal Muscular Atrophy (SMA), *Parkinson's Disease (PD), Stroke, and Spinal Cord Injury (SCI), and Unruptured Cerebral Aneurysms and Subarachnoid Hemorrhage (SAH)
 
*Indicated for studies requiring a Global Health-Related Quality of Life measure. Provides extensive comparison data to other disease areas.
 
Exploratory: Cerebral Palsy (CP) Myotonic Muscular Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD) and Sport-Related Concussion (SRC)
Short Description of Instrument
The Patient Reported Outcomes Measurement Information System (PROMIS) Scale v1.2 - Global Health (also referred to as PROMIS-10) is a ten-item patient reported measure of physical, mental and social health. Items query general health, quality of life, physical health, mental health, satisfaction with discretionary social activities, carrying out every day physical activities, pain, fatigue, satisfaction with social roles, and emotional problems (Hays et al., 2009). See List of Adult Measures for details.
 
PROMIS contains calibrated item banks with Likert style items for approximately 70 domains (e.g., anger, anxiety, depression, fatigue (Cella et al., 2010; Garcia et al., 2007), pain (Amtmann et al., 2010), physical function, satisfaction with social activities and roles, sleep/wake disturbance, and global health (Cella et al., 2010; Hays et al., 2009)). It is part of the NIH goal to develop systems to support NIH-funded research supported by all of its institutes and centers. PROMIS measures cover physical, mental, and social health and can be used across chronic conditions.
 
NeuroRehab-Specific: PROMIS Global is a measure of how a person evaluates their overall mental and physical health.
 
Stroke-Specific: Version 1.1 of this scale is recommended by the International Consortium for Health Outcomes Measurement Working Group as part of the Stroke Standard Set of outcome measures (Salinas et al., 2016). The psychometric properties in ischemic stroke and intracerebral hemorrhage patients, and comparison to other PROMIS domain scales were studied by Katzan and Lapin (2018). Version 1.2 of the scale includes changes to allow item response theory scoring in computer scoring applications but does not include changes to the syntax of items; see Scoring Manual for additional details. Lapin et al., 2018 found that updates to the scoring methodology did not change the conclusions of their previous validation study (Katzan and Lapin 2018).
 
Parkinson's Disease-Specific: The PROMIS system is widely used and has extensive general validation data. The scale has been used in PD, but not specifically validated in PD.
 
Administration: Fixed length scale
 
Time: 2-5 minutes
 
Ages: Adult ages 18+.
 
Cost: No licensing or royalty fees for English and Spanish PROMIS measures used in individual research, clinical practice, educational assessment or other application. Translations in other languages have a distribution fee. Permission is required for commercial use or integration into proprietary technology; see PROMIS Terms and Conditions of Use for details.
 
Available in Spanish and in multiple other languages; see PROMIS Translations for details.
Comments/Special Instructions
N/A
Scoring and Psychometric Properties
Scoring: The PROMIS Scale v1.2 - Global Health has two scores: Physical Health (physical health, physical function, pain, and fatigue items) and Mental Health (quality of life, mental health, satisfaction with discretionary social activities, and emotional problem items) (Hays et al., 2009).
 
T scores for both Physical and Mental Health scales.
 
In all cases, a high score means more of domain. For example, higher scores on the fatigue measures indicate poorer health whereas higher scores on physical functioning measure indicate better health.
 
Standardization Population: For most domains, T-scores relate to the US General Population. See PROMIS Calibrations Testing for further details regarding sample for specific ages and domains.
 
Scoring Manuals are available at: PROMIS Scoring Manuals
 
Psychometric Properties: Substantial qualitative and quantitative evidence has been gathered that supports the validity and reliability of PROMIS measures. More information about validation is available at: PROMIS Validation
Rationale/Justification
Parkinson's Disease-Specific:
Strengths: The PROMIS Scale v1.2 Global Health has been validated across a broad range of chronic disease. Two summary scores can be calculated that are relevant in PD.
 
Weaknesses: It has less domain-specific information than the PROMIS 29 Profile. There is little validation in specific conditions (e.g., PD).
References
Key References:
Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009 Sep;18(7):873-80.
 
See a list of primary citations for PROMIS measures here: Primary Citations for PROMIS Measures
 
Additional References:
Allen J, Alpass FM, Stephens CV. The sensitivity of the MOS SF-12 and PROMIS® global summary scores to adverse health events in an older cohort. Qual Life Res. 2018 Aug;27(8):2207-2215.
 
Amtmann D, Cook KF, Jensen MP, Chen WH, Choi S, Revicki D, Cella D, Rothrock N, Keefe F, Callahan L, Lai JS. Development of a PROMIS item bank to measure pain interference. Pain. 2010 Jul;150(1):173-182.
 
Barile JP, Reeve BB, Smith AW, Zack MM, Mitchell SA, Kobau R, Cella DF, Luncheon C, Thompson WW. Monitoring population health for Healthy People 2020: evaluation of the NIH PROMIS® Global Health, CDC Healthy Days, and satisfaction with life instruments. Qual Life Res. 2013 Aug;22(6):1201-11.
 
Blumenthal KJ, Chang Y, Ferris TG, Spirt JC, Vogeli C, Wagle N, Metlay JP. Using a Self-Reported Global Health Measure to Identify Patients at High Risk for Future Healthcare Utilization. J Gen Intern Med. 2017 Aug;32(8):877-882.
 
Bruni O, Ottaviano S, Guidetti V, Romoli M, Innocenzi M, Cortesi F, Giannotti F. The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. J Sleep Res. 1996 Dec;5(4):251-61.
 
Bruni O, Romoli M., Innocenzi M, Giannotti F, Cortesi F and Ottaviano S. Prevalenza dei disturbi del sonno in eth scolare. In: Di Perri R., Raffaele M., Silvestri R. and Smirne S. (Eds) 11 Sonno in ltaliu 1994. Poletto Ed., Milano, 1994 163-171.
 
Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, Amtmann D, Bode R, Buysse D, Choi S, Cook K, Devellis R, DeWalt D, Fries JF, Gershon R, Hahn EA, Lai JS, Pilkonis P, Revicki D, Rose M, Weinfurt K, Hays R; PROMIS Cooperative Group. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010 Nov;63(11):1179-1194.
 
Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, Ader D, Fries JF, Bruce B, Rose M; PROMIS Cooperative Group. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007 May;45(5 Suppl 1):S3-S11.
 
Garcia SF, Cella D, Clauser SB, Flynn KE, Lad T, Lai JS, Reeve BB, Smith AW, Stone AA, Weinfurt K. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol. 2007 Nov 10;25(32):5106-12. Erratum in: J Clin Oncol. 2008 Feb 20;26(6):1018. Lad, Thomas [added].
 
Gruber-Baldini AL, Velozo C, Romero S, Shulman LM. Validation of the PROMIS® measures of self-efficacy for managing chronic conditions. Qual Life Res. 2017 Jul;26(7):1915-1924.
 
Hays RD, Revicki DA, Feeny D, Fayers P, Spritzer KL, Cella D. Using Linear Equating to Map PROMIS(®) Global Health Items and the PROMIS-29 V2.0 Profile Measure to the Health Utilities Index Mark 3. Pharmacoeconomics. 2016 Oct;34(10):1015-22.
 
Hinami K, Smith J, Deamant CD, DuBeshter K, Trick WE. When do patient-reported outcome measures inform readmission risk? J Hosp Med. 2015 May;10(5):294-300.
 
Kobau R, Cui W, Zack MM. Adults with an epilepsy history fare significantly worse on positive mental and physical health than adults with other common chronic conditions-Estimates from the 2010 National Health Interview Survey and Patient Reported Outcome Measurement System (PROMIS) Global Health Scale. Epilepsy Behav. 2017 Jul;72:182-184.
 
Revicki DA, Kawata AK, Harnam N, Chen WH, Hays RD, Cella D. Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample. Qual Life Res. 2009 Aug;18(6):783-91.
 
Shulman LM, Velozo C, Romero S, Gruber-Baldini AL. Comparative study of PROMISⓇ self-efficacy for managing chronic conditions across chronic neurologic disorders. Qual Life Res. 2019 Jul;28(7):1893-1901.
 
Spruyt K, Gozal D. Pediatric sleep questionnaires as diagnostic or epidemiological tools: a review of currently available instruments. Sleep Med Rev. 2011 Feb;15(1):19-32.
 
Thompson NR, Lapin BR, Katzan IL. Mapping PROMIS Global Health Items to EuroQol (EQ-5D) Utility Scores Using Linear and Equipercentile Equating. Pharmacoeconomics. 2017 Nov;35(11):1167-1176.
 
Thompson NR, Katzan IL, Honomichl RD, Lapin BR. PROMIS Global Health item nonresponse: is it better to impute missing item responses before computing T-scores? Qual Life Res. 2020 Feb;29(2):537-546.
 
NeuroRehab-Specific References:
De Graaf JA, Visser-Meily JM, Schepers VP, Baars A, Kappelle LJ, Passier PE, Wermer MJ, DE Wit DC, Post MW. Comparison between EQ-5D-5L and PROMIS-10 to evaluate health-related quality of life 3 months after stroke: a cross-sectional multicenter study. Eur J Phys Rehabil Med. 2021 Jun;57(3):337-346.
 
De Marchi F, Berry JD, Chan J, Caldwell S, Ellrodt A, Scalia J, Burke K, Fang T, Clark Sisodia R, Schwamm LH, Moura LMVR, Paganoni S. Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis. J Neurol. 2020 Jun; 267(6): 1754-1759.
 
Katzan IL, Thompson N, Schuster A, Wisco D, Lapin B. Patient-Reported Outcomes Predict Future Emergency Department Visits and Hospital Admissions in Patients With Stroke. J Am Heart Assoc. 2021 Mar 16;10(6):e018794.
 
Morris TP, Tormos Muñoz JM, Cattaneo G, Solana-Sánchez J, Bartrés-Faz D, Pascual-Leone A. Traumatic Brain Injury Modifies the Relationship Between Physical Activity and Global and Cognitive Health: Results From the Barcelona Brain Health Initiative. Front Behav Neurosci. 2019 Jun 19;13:135.
 
Newey CR, Thompson NR, George P, Punia V, Hantus S, Lapin B, Gomes J, Katzan I. Patient-Reported Outcomes (PROs) in Acute Symptomatic Seizure (ASyS) Versus Patients With Established Epilepsy. Neurohospitalist. 2020 Jul;10(3):193-200.
 
Stroke-Specific References:
Katzan IL, Lapin B. PROMIS GH (Patient-Reported Outcomes Measurement Information System Global Health) Scale in Stroke: A Validation Study. Stroke. 2018 Jan;49(1):147-154.
 
Lam KH, Kwa VIH. Validity of the PROMIS-10 Global Health assessed by telephone and on paper in minor stroke and transient ischaemic attack in the Netherlands. BMJ Open. 2018 Jul 11;8(7):e019919.
 
Lapin B, Thompson NR, Katzan IL. Letter by Lapin et al Regarding Article, "PROMIS GH (Patient-Reported Outcomes Measurement Information System Global Health) Scale in Stroke: A Validation Study". Stroke. 2018 May;49(5):e214.
 
Lapin BR, Thompson NR, Schuster A, Katzan IL. Patient versus proxy response on global health scales: no meaningful DIFference. Qual Life Res. 2019 Jun;28(6):1585-1594.
 
Reeves MJ, Hughes AK, Woodward AT, Freddolino PP, Coursaris CK, Swierenga SJ, Schwamm LH, Fritz MC. Improving transitions in acute stroke patients discharged to home: the Michigan stroke transitions trial (MISTT) protocol. BMC Neurol. 2017 Jun 17;17(1):115.
 
Salinas J, Sprinkhuizen SM, Ackerson T, Bernhardt J, Davie C, George MG, Gething S, Kelly AG, Lindsay P, Liu L, Martins SC, Morgan L, Norrving B, Ribbers GM, Silver FL, Smith EE, Williams LS, Schwamm LH. An International Standard Set of Patient-Centered Outcome Measures After Stroke. Stroke. 2016 Jan;47(1):180-6.
 
Document last updated May 2024